Clinical Trial Update: Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update on LE051 evaluating safety, tolerability, and potential efficacy in Duchenne Muscular Dystrophy; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• LE051

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Duchenne Muscular Dystrophy (DMD) | EARLY_Phase 1 | Status: RECRUITING